Valuation dashboard for Bruker Corporation (BRKR) with P/E N/A, P/B 4.01, EV/EBITDA 46.23 and dividend yield 0.32%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies.
Analysis Summary
Bruker Corporation reported revenue of $3.44B in the most recent fiscal year, growing at a 5-year CAGR of 11.6%.
Trailing-twelve-month margins: gross margin 46.7%, operating margin 3.6%, net margin -2.0%.
At the current price of $63.86, BRKR has negative trailing earnings (P/E not meaningful) and an ROE of -2.92%. Market capitalisation stands at $9.7B.
Balance sheet quality for BRKR: current ratio of 1.7. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 4.01 |
| EV / EBITDA | 46.23 |
| Dividend Yield | 0.32% |
Valuation Models
| DCF Fair Value | $30.47 |
| vs Current Price | -52.3% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| BRKR | Bruker Corporation | $9.7B | 4.01 | -2.9% | |
| BTSG | BrightSpring Health Services, Inc. Common Stock | $11.8B | 43.36 | 6.24 | 15.2% |
| KRYS | Krystal Biotech, Inc. | $9.6B | 38.97 | 7.00 | 16.8% |
| CRSP | CRISPR Therapeutics AG | $5.3B | 3.06 | -30.3% | |
| MMSI | Merit Medical Systems, Inc. | $5.1B | 40.62 | 3.29 | 8.1% |
| IRTC | iRhythm Technologies, Inc. | $3.6B | 19.31 | -9.0% | |
| GKOS | Glaukos Corporation | $9.4B | 14.02 | -28.6% | |
| CHE | Chemed Corporation | $6.6B | 25.48 | 8.20 | 29.5% |
Price
| Price | $63.86 |
| Market Cap | $9.7B |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -2.92% |
| Return on Invested Capital | 2.56% |
| Return on Assets | -1.18% |
| Gross Margin | 46.69% |
| Operating Margin | 3.61% |
| Net Margin | -2.03% |
Related companies: BTSG · CHE · CRSP · GKOS · IRTC · KRYS · MMSI
Explore sector: Healthcare · Medical - Devices
More sections of BRKR: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks